Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer.
Saira KhanSu-Hsin ChangAmanda A SeyerleMei WangVeronica HicksBettina F DrakePublished in: The Prostate (2023)
Post-diagnostic metformin and statin use have the potential to prevent biochemical recurrence in men diagnosed with prostate cancer.